Mustang Bio Inc
MBIO
NASDAQ
Biotechnology
$0.59
USD
0.00 (-0.08%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.53M
Volume 11.6K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-3.03M
TTM
+7.4%
YoY
Operating Cash Flow
$-4.51M
TTM
+30.4%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 0.8 | 1.0 | 1.0 | 0.9 | 0.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 0.9 | 0.6 | 0.7 | 1.1 | 1.2 |
Operating Income | -0.9 | -0.6 | -0.7 | -1.1 | -1.2 |
EBITDA | -0.9 | -0.6 | -0.7 | -1.1 | -1.2 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
Income Before Income Taxes | -0.8 | -0.5 | -0.5 | -1.0 | -1.1 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -0.8 | -0.5 | -0.5 | -1.0 | -1.1 |
Consolidated Net Income / Loss | -0.8 | -0.5 | -0.5 | -1.0 | -1.1 |
Net Income Attributable to Common Shareholders | -0.8 | -0.5 | -0.5 | -1.0 | -1.1 |
Basic EPS | -$0.19 | -$0.07 | -$0.08 | -$0.14 | -$0.16 |
Diluted EPS | -$0.19 | -$0.07 | -$0.08 | -$0.14 | -$0.16 |
Basic Shares Outstanding | 4.0M | 6.2M | 6.5M | 6.7M | 6.7M |
Diluted Shares Outstanding | 4.0M | 6.2M | 6.5M | 6.7M | 6.7M |